Dementia

The effect of APOE4 on neurovascular coupling

Use of AD blood-based biomarkers for trial enrolment

Expanding research into biomarkers for RPD differentiation

Characterizing protein accumulation in primary vulnerable neurons in Alzheimer’s disease

Investigating the link between APOE4, vascular function, & Alzheimer’s disease onset

Epigenome-wide association study of psychosis in Alzheimer’s disease

How feasible is an Alzheimer’s disease blood test in the UK?

Diagnostic biomarkers on the horizon in Alzheimer’s disease

TREM2 as a target for disease modification in Alzheimer’s disease

Why have anti-amyloid monoclonal antibodies performed differently in Phase III trials

Hearing loss and dementia

The power of composite tests to track Alzheimer’s disease progression

Trends in the use of surrogate biomarkers during clinical trials

Streamlining dementia diagnosis with digital biomarkers

Best outcome measures for Alzheimer’s disease follow-up in the clinic

TRAILBLAZER-ALZ 4: direct comparison of donanemab and aducanumab